Obeticholic acid (OCA), a semisynthetic derivative of the natural bile acid chenodeoxycholic acid, can improve insulin sensitivity and reduce biomarkers of liver fibrosis in NAFLD patients with type 2 diabetes mellitus [102]. The gene discussed is INS; the disease is Hepatic fibrosis.